Cheetah
Deity
We might find out in a few hours...
From the bits of leaked information I've seen, this is probably going to be bad, and if it's done now, I think a thread is in order to discuss the implications.
Edit: Seems it's done.
https://twitter.com/RichardMadan/status/650721578523717636
UPDATE:
The full text is out!
Reuters: Japanese economy minster says preparing news conference with expectation of announcing overall #TPP deal later today.
From the bits of leaked information I've seen, this is probably going to be bad, and if it's done now, I think a thread is in order to discuss the implications.
Edit: Seems it's done.
https://twitter.com/RichardMadan/status/650721578523717636
A burst of energy filled hotel after word #TPP deal reached. I'm up live on @ctvnewschannel in moments to bring latest #elxn42
UPDATE:
The full text is out!
SourceOne of the most controversial chapters in the deal concerns intellectual property. In an e-mail to Ars, James Love, the director of Knowledge Ecology International, said:Meanwhile, the deal also exports US copyright law regarding how long a copyright lasts. The plan, which now needs approval from all the pact's member nations, makes copyrights last for the life of the creator plus 70 years after death. That's basically the same as in the US.In the IP Chapter, the TPP locks in a number of anti-consumer measures, and imposes higher standards for IP on poor countries, after their transition periods. One impact of the IP chapter is to gut provisions in US law to encourage more transparency of patents on biologic drugs, and to make infringement of any patent or copyright more risky and costly.
In the investment chapter, the TPP gives private companies the right to bring cases and get fines when a country does not meet its obligations, for the IP chapter, and for pretty much all the other chapters too.
In the transparency annex, the TPP requires countries to give drug companies more rights to monitor and challenge government decisions on reimbursements on drugs, basically to hassle and sue governments when they push back on high drug prices.